Brittany Liebenow1, Abigail Tatter2, William A Dezarn3, Scott Isom4, Michael D Chan3, Stephen B Tatter2. 1. Departments of Neurosurgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA. bliebeno@wakehealth.edu. 2. Departments of Neurosurgery, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA. 3. Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
PURPOSE: This is the first single-institution study of its size to characterize the treatment impact and to address the question of whether hemangioblastoma treatment with Gamma Knife Stereotactic Radiosurgery (GKRS) in both sporadic and VHL patients changes the characteristic saltatory hemangioblastoma growth pattern. METHODS: The authors reviewed a single-institution tumor registry to identify patients who had received GKRS for hemangioblastomas between January 1st, 1999, and December 31st, 2017. RESULTS: 15 patients with 101 lesions met search criteria with a median age of first GKRS of 39.2 years (interquartile range [IQR] of 25.7-57.4 years), including 96 VHL and 5 sporadic lesions. The median time from GKRS to last follow-up was 5.4 years (IQR 2.3-11.5 years). 4 lesions (4%) and 3 patients (20%) experienced a local failure. The 1-year, 3-year, and 5-year freedom from new hemangioblastoma formation rates were 97%, 80%, and 46% respectively. Multivariate analysis revealed a reduction in tumor volume after GKRS. Several variables associated with a greater percent reduction in volume from GKRS to last follow-up: non-cystic status (p = .01), no prior craniotomy (p = .04), and follow-up time from GKRS (p < .0001). CONCLUSIONS: GKRS is a successful long-term treatment option for hemangioblastomas changing the clinical course from saltatory growth to reduction in tumor volume. Non-cystic tumors and those without prior craniotomy were associated with a greater percent reduction in volume from GKRS at last follow-up.
PURPOSE: This is the first single-institution study of its size to characterize the treatment impact and to address the question of whether hemangioblastoma treatment with Gamma Knife Stereotactic Radiosurgery (GKRS) in both sporadic and VHLpatients changes the characteristic saltatory hemangioblastoma growth pattern. METHODS: The authors reviewed a single-institution tumor registry to identify patients who had received GKRS for hemangioblastomas between January 1st, 1999, and December 31st, 2017. RESULTS: 15 patients with 101 lesions met search criteria with a median age of first GKRS of 39.2 years (interquartile range [IQR] of 25.7-57.4 years), including 96 VHL and 5 sporadic lesions. The median time from GKRS to last follow-up was 5.4 years (IQR 2.3-11.5 years). 4 lesions (4%) and 3 patients (20%) experienced a local failure. The 1-year, 3-year, and 5-year freedom from new hemangioblastoma formation rates were 97%, 80%, and 46% respectively. Multivariate analysis revealed a reduction in tumor volume after GKRS. Several variables associated with a greater percent reduction in volume from GKRS to last follow-up: non-cystic status (p = .01), no prior craniotomy (p = .04), and follow-up time from GKRS (p < .0001). CONCLUSIONS: GKRS is a successful long-term treatment option for hemangioblastomas changing the clinical course from saltatory growth to reduction in tumor volume. Non-cystic tumors and those without prior craniotomy were associated with a greater percent reduction in volume from GKRS at last follow-up.
Entities:
Keywords:
Gamma Knife; Hemangioblastoma; Oncology; Sporadic; Stereotactic radiosurgery; Von Hippel-Lindau
Authors: Albert Attia; Michael D Chan; Ryan T Mott; Greg B Russell; David Seif; J Daniel Bourland; Allan F Deguzman; Thomas L Ellis; Kevin P McMullen; Michael T Munley; Stephen B Tatter; Edward G Shaw Journal: J Neurooncol Date: 2012-02-23 Impact factor: 4.130
Authors: Danilo Silva; Mathew M Grabowski; Rupa Juthani; Mayur Sharma; Lilyana Angelov; Michael A Vogelbaum; Samuel Chao; John Suh; Alireza Mohammadi; Gene H Barnett Journal: J Clin Neurosci Date: 2016-07-13 Impact factor: 1.961
Authors: Ann Liu; Elizabeth N Kuhn; John T Lucas; Adrian W Laxton; Stephen B Tatter; Michael D Chan Journal: J Neurosurg Date: 2015-01-02 Impact factor: 5.408
Authors: Salvatore D' Oria; David Giraldi; Daniel Andres Alvarado Flores; Domenico Murrone; Vincenzo D' Angelo; Bipin Chaurasia Journal: J Craniovertebr Junction Spine Date: 2022-09-14